Fri, January 19, 2018
Thu, January 18, 2018
Wed, January 17, 2018
Tue, January 16, 2018
Fri, January 12, 2018
Thu, January 11, 2018
Wed, January 10, 2018
Tue, January 9, 2018
Mon, January 8, 2018
Fri, January 5, 2018
Thu, January 4, 2018
Wed, January 3, 2018
Tue, January 2, 2018
Tue, December 26, 2017
Fri, December 22, 2017
Thu, December 21, 2017
Wed, December 20, 2017
Tue, December 19, 2017
Mon, December 18, 2017
Fri, December 15, 2017
Thu, December 14, 2017
Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017

Vijay Kumar Initiated (ABT) at Buy and Held Target at $64 on, Jan 3rd, 2018


//stocks-investing.news-articles.net/content/201 .. t-buy-and-held-target-at-64-on-jan-3rd-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Vijay Kumar of Evercore ISI Group, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $64 on, Jan 3rd, 2018.

Vijay has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 1 agrees with Vijay's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017


These are the ratings of the 4 analyists that currently disagree with Vijay


  • David Lewis of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, January 2nd, 2018
  • Michael Weinstein of "JP Morgan" Upgraded from Hold to Buy on, Tuesday, January 2nd, 2018
  • Joanne Wuensch of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $65 on, Tuesday, December 12th, 2017
  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017

Publication Contributing Sources